Efalizumab for the treatment of moderate to severe psoriasis

Abstract

We report two patients with moderate and severe psoriasis treated successfully with efalizumab, which is modern biologic drug for long-lasting control of difficult cases of psoriasis.

Keywords

• psoriasis
• efalizumab